511 related articles for article (PubMed ID: 31679863)
1. Effect of donor funding for immunization from Gavi and other development assistance channels on vaccine coverage: Evidence from 120 low and middle income recipient countries.
Ikilezi G; Augusto OJ; Dieleman JL; Sherr K; Lim SS
Vaccine; 2020 Jan; 38(3):588-596. PubMed ID: 31679863
[TBL] [Abstract][Full Text] [Related]
2. Tracking donor funding towards achieving the Global Vaccine Action Plan (GVAP) goals: A landscape analysis (1990-2016).
Ikilezi G; Zlavog B; Augusto OJ; Sherr K; Lim SS; Dieleman JL
Vaccine; 2018 Nov; 36(49):7487-7495. PubMed ID: 30366804
[TBL] [Abstract][Full Text] [Related]
3. Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).
Le Gargasson JB; Breugelmans JG; Mibulumukini B; Da Silva A; Colombini A
Vaccine; 2013 Apr; 31(15):1886-91. PubMed ID: 23462529
[TBL] [Abstract][Full Text] [Related]
4. Costs of Immunization Programs for 10 Vaccines in 94 Low- and Middle-Income Countries From 2011 to 2030.
Sim SY; Watts E; Constenla D; Huang S; Brenzel L; Patenaude BN
Value Health; 2021 Jan; 24(1):70-77. PubMed ID: 33431156
[TBL] [Abstract][Full Text] [Related]
5. Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs.
Kallenberg J; Mok W; Newman R; Nguyen A; Ryckman T; Saxenian H; Wilson P
Health Aff (Millwood); 2016 Feb; 35(2):250-8. PubMed ID: 26858377
[TBL] [Abstract][Full Text] [Related]
6. Global rotavirus vaccine introductions and coverage: 2006 - 2016.
Abou-Nader AJ; Sauer MA; Steele AD; Tate JE; Atherly D; Parashar UD; Santosham M; Nelson EAS
Hum Vaccin Immunother; 2018; 14(9):2281-2296. PubMed ID: 29787334
[TBL] [Abstract][Full Text] [Related]
7. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
Peny JM; Gleizes O; Covilard JP
Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
[TBL] [Abstract][Full Text] [Related]
8. Costs of vaccine programs across 94 low- and middle-income countries.
Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
[TBL] [Abstract][Full Text] [Related]
9. Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisms through an equity lens (1999-2014).
Gandhi G
BMC Public Health; 2015 Nov; 15():1198. PubMed ID: 26621528
[TBL] [Abstract][Full Text] [Related]
10. Economic Benefits of Immunization for 10 Pathogens in 94 Low- and Middle-Income Countries From 2011 to 2030 Using Cost-of-Illness and Value-of-Statistical-Life Approaches.
Watts E; Sim SY; Constenla D; Sriudomporn S; Brenzel L; Patenaude B
Value Health; 2021 Jan; 24(1):78-85. PubMed ID: 33431157
[TBL] [Abstract][Full Text] [Related]
11. Vaccine Assistance To Low- And Middle-Income Countries Increased To $3.6 Billion In 2014.
Haakenstad A; Birger M; Singh L; Liu P; Lim S; Ng M; Dieleman JL
Health Aff (Millwood); 2016 Feb; 35(2):242-9. PubMed ID: 26858376
[TBL] [Abstract][Full Text] [Related]
12. Trends in vaccine investment in middle income countries.
Onishchenko K; Hill S; Wasserman M; Jones C; Moffatt M; Ruff L; Pugh SJ
Hum Vaccin Immunother; 2019; 15(10):2378-2385. PubMed ID: 30843757
[TBL] [Abstract][Full Text] [Related]
13. Health and economic impact of rotavirus vaccination in GAVI-eligible countries.
Kim SY; Sweet S; Slichter D; Goldie SJ
BMC Public Health; 2010 May; 10():253. PubMed ID: 20470426
[TBL] [Abstract][Full Text] [Related]
14. Applying lessons learned from the USAID family planning graduation experience to the GAVI graduation process.
Shen AK; Farrell MM; Vandenbroucke MF; Fox E; Pablos-Mendez A
Health Policy Plan; 2015 Jul; 30(6):687-95. PubMed ID: 24974106
[TBL] [Abstract][Full Text] [Related]
15. Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011-2020.
Gandhi G; Lydon P; Cornejo S; Brenzel L; Wrobel S; Chang H
Vaccine; 2013 Apr; 31 Suppl 2():B137-48. PubMed ID: 23598475
[TBL] [Abstract][Full Text] [Related]
16. Status of New Vaccine Introduction - Worldwide, September 2016.
Loharikar A; Dumolard L; Chu S; Hyde T; Goodman T; Mantel C
MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(41):1136-1140. PubMed ID: 27764083
[TBL] [Abstract][Full Text] [Related]
17. Strategic donor behaviour and country vulnerability in health aid transitions.
Mao W; McDade KK; Ogbuoji O; Yamey G; Bermeo SB
BMJ Glob Health; 2023 Nov; 8(11):. PubMed ID: 37940202
[TBL] [Abstract][Full Text] [Related]
18. Effect of the Global Alliance for Vaccines and Immunisation on diphtheria, tetanus, and pertussis vaccine coverage: an independent assessment.
Lu C; Michaud CM; Gakidou E; Khan K; Murray CJ
Lancet; 2006 Sep; 368(9541):1088-95. PubMed ID: 16997663
[TBL] [Abstract][Full Text] [Related]
19. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
[TBL] [Abstract][Full Text] [Related]
20. Estimating total spending by source of funding on routine and supplementary immunisation activities in low-income and middle-income countries, 2000-17: a financial modelling study.
Ikilezi G; Micah AE; Bachmeier SD; Cogswell IE; Maddison ER; Stutzman HN; Tsakalos G; Brenzel L; Dieleman JL
Lancet; 2021 Nov; 398(10314):1875-1893. PubMed ID: 34742369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
